[HTML][HTML] Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection
TC Zhao - Cardiovascular diabetology, 2013 - Springer
Abstract Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection
TC Zhao - Cardiovascular Diabetology, 2013 - go.gale.com
Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family implicated
in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic, and …
in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic, and …
Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection
TC Zhao - Cardiovascular Diabetology, 2013 - search.proquest.com
Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family implicated
in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic, and …
in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic, and …
[PDF][PDF] Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection
TC Zhao - 2013 - cyberleninka.org
Abstract Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection.
TC Zhao - Cardiovascular Diabetology, 2013 - europepmc.org
Abstract Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
[HTML][HTML] Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection
TC Zhao - Cardiovascular Diabetology, 2013 - ncbi.nlm.nih.gov
Abstract Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection
TC Zhao - Cardiovascular diabetology, 2013 - pubmed.ncbi.nlm.nih.gov
Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family implicated
in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic, and …
in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic, and …
Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection.
TC Zhao - Cardiovascular Diabetology, 2013 - search.ebscohost.com
Abstract Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
[HTML][HTML] Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection
TC Zhao - Cardiovascular Diabetology, 2013 - cardiab.biomedcentral.com
Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family implicated
in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic, and …
in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic, and …
[PDF][PDF] Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection
TC Zhao - 2013 - scienceopen.com
Abstract Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …
implicated in the control of appetite and satiety. GLP-1 has insulinotropic, insulinomimetic …